Xconomy

From Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial:

Rib-X logo
Rib-X logo

Rib-X Pharmaceuticals is developing next-generation antibiotics.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.